KEAP1 and diabetes mellitus: Consistent with these findings, our study demonstrates AR/PCC treatment significantly counteracts the elevated expression of Keap1 and the reduced expression of Nrf2 in DM rats, indicating that AR/PCC can safeguard against oxidative stress in the vertebral bodies of DM rats.